Condition
Testosterone Deficiency
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownImpact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomyNCT04833426 · 2022-12-12
RECRUITINGTestosterone Treatment for Erectile Dysfunction and Multiple SclerosisNCT04601233 · 2026-06-01
WITHDRAWNExploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenNCT05773183 · 2023-03-12
UNKNOWNPhysical Exercise for Men With AndropauseNCT03150225 · 2019-04-01
UNKNOWNEffect of Testosterone in Men With Erectile DysfunctionNCT00512707 · 2006-11-01
COMPLETEDCommon interventions
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Trial status mix
UNKNOWN2
COMPLETED1
RECRUITING1
WITHDRAWN1
Phase mix
PHASE42
NA1
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.